PRESS STATEMENT FROM JOHN ROTHER

FDA Approves Repatha, New Cholesterol-Lowering Treatment

See more
JOHN ROTHER IN THE AJMC

Prescription Drug Pricing: Give the People What They Want

See more
PRESS STATEMENT FROM JOHN ROTHER

New KFF Poll: Unsustainable drug pricing moves ahead of ACA as GOP voters’ top health care concern

See more

Are Skyrocketing Drug Prices Really Needed for Innovation?

Read More
Want to learn more? Let us know how to reach you for updates.


WHAT CAN HIGH DRUG PRICES DO TO US?
  • Threaten access to care
  • Raise out of pocket costs
  • Create higher premiums
  • Raise taxes
  • Threaten care infrastructure
Need More info?
Please reach out to us with any questions.

Contact Us

  • "There are no multiple sclerosis drugs available in the United States with a list price below $50,000 a year"

  • U.S. spending on prescription drugs saw the largest increase since 2001, with the nation’s pharmacy bill rising to $373.9 billion last year as new treatments came to market and manufacturers increased prices on old ones.

  • circle-person-60px

    For the price of Sovaldi for one patient, we could provide health insurance through Medicaid for [up to] 26 people for an entire year.

  • circle-person-60px

    [Solvadi's price] has the potential to throw a wrench into short-term state budgets.

Learn more about how you can help bring reasonable drug prices to this country.

Contact Us